A DECADE IN THE MAKING: OREO RETURNS TO THE BIG GAME IN 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
These 6 stocks are new Top Picks at Jefferies
December 20, 2023 3:51 PM ESTJefferies' Franchise Picks represent their analysts most confident, Buy-rated stocks within the research companys US Research portfolio. These top selections are backed by thorough analysis, distinct factors, and favorable valuations indicating potential for growth.
This month, Jefferies added 6 new ideas to the list.
argenx SE
argenx (NASDAQ: ARGX) was added to the list as Jefferies analysts consider the biotechnology companys s lead asset, Vyvgart, to be a best-in-class drug owing to its potent IgG drops, clean safety profile without dose-limiting albumin drops or effector-related adverse events, and convenient... More
